TELA Bio, Inc. (TELA)
0.965
-0.04
(-4.46%)
USD |
NASDAQ |
Oct 23, 16:00
0.9907
+0.03
(+2.66%)
After-Hours: 20:00
TELA Bio Enterprise Value : 69.45M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 69.45M |
| October 22, 2026 | 71.47M |
| October 21, 2026 | 74.61M |
| October 20, 2026 | 75.06M |
| October 19, 2026 | 69.69M |
| October 16, 2026 | 69.90M |
| October 15, 2026 | 71.47M |
| October 14, 2026 | 75.28M |
| October 13, 2026 | 73.94M |
| October 12, 2026 | 74.61M |
| October 09, 2026 | 75.95M |
| October 08, 2026 | 73.26M |
| October 07, 2026 | 74.16M |
| October 06, 2026 | 75.06M |
| October 05, 2026 | 77.30M |
| October 02, 2026 | 77.30M |
| October 01, 2026 | 82.23M |
| September 30, 2026 | 77.75M |
| September 29, 2026 | 81.78M |
| September 28, 2026 | 81.33M |
| September 25, 2026 | 82.68M |
| September 24, 2026 | 83.13M |
| September 23, 2026 | 84.47M |
| September 22, 2026 | 89.40M |
| September 21, 2026 | 84.47M |
| Date | Value |
|---|---|
| September 18, 2026 | 82.23M |
| September 17, 2026 | 84.02M |
| September 16, 2026 | 79.09M |
| September 15, 2026 | 75.06M |
| September 14, 2026 | 72.81M |
| September 11, 2026 | 69.68M |
| September 10, 2026 | 66.77M |
| September 09, 2026 | 67.04M |
| September 08, 2026 | 63.40M |
| September 04, 2026 | 63.02M |
| September 03, 2026 | 61.20M |
| September 02, 2026 | 59.92M |
| September 01, 2026 | 61.66M |
| August 31, 2026 | 59.27M |
| August 28, 2026 | 57.57M |
| August 27, 2026 | 55.33M |
| August 26, 2026 | 57.17M |
| August 25, 2026 | 57.57M |
| August 24, 2026 | 55.51M |
| August 21, 2026 | 55.16M |
| August 20, 2026 | 54.85M |
| August 19, 2026 | 55.19M |
| August 18, 2026 | 55.02M |
| August 17, 2026 | 55.33M |
| August 14, 2026 | 55.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
| Baxter International, Inc. | 19.76B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.26M |
| Revenue (Quarterly) | 19.29M |
| Total Expenses (Quarterly) | 30.55M |
| EPS Diluted (Quarterly) | -0.1962 |
| Gross Profit Margin (Quarterly) | 72.28% |
| Profit Margin (Quarterly) | -58.38% |
| Earnings Yield | -80.30% |
| Normalized Earnings Yield | -79.05 |